Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate (Q35048395)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate |
scientific article |
Statements
1 reference
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate (English)
1 reference
Edward C Keystone
1 reference
Peter C Taylor
1 reference
Edit Drescher
1 reference
Douglas E Schlichting
1 reference
Scott D Beattie
1 reference
Pierre-Yves Berclaz
1 reference
Chin H Lee
1 reference
Rosanne K Fidelus-Gort
1 reference
Monica E Luchi
1 reference
Terence P Rooney
1 reference
William L Macias
1 reference
Mark C Genovese
1 reference
27 November 2014
1 reference
1 reference
74
1 reference
2
1 reference
333-340
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference